Showing results (91-100 of 310) with videos related to
Sort By:
Pageof 31
Biochemical Pharmacology|May 15, 1985
Benzo[a]pyrene metabolism in mouse liver. Association of both 7,8-epoxidation and covalent binding of a metabolite of the 7,8-diol with the Ah locusJ Van Cantfort, J E Gielen, D W NebertPharmacology|January 1, 1979
2,3,7,8-Tetrachlorodibenzo-p-dioxin: covalent binding of reactive metabolic intermediates principally to protein in vitroT M Guenthner, J M Fysh, D W NebertScience (New York, N.Y.)|April 5, 1985
Human dioxin-inducible cytochrome P1-450: complementary DNA and amino acid sequenceA K Jaiswal, F J Gonzalez, D W NebertCancer Research|December 1, 1976
Genetic control of interindividual variations in the inducibility of aryl hydrocarbon hydroxylase in cultured human lymphocytesS A Atlas, E S Vesell, D W NebertThe Journal of Biological Chemistry|November 25, 1986
NAD(P)H:menadione oxidoreductase. Novel purification of enzyme cDNA and complete amino acid sequence, and gene regulationJ A Robertson, H C Chen, D W NebertBiochemical Pharmacology|August 17, 1994
Lack of response of the rat liver "class 3" cytosolic aldehyde dehydrogenase to toxic chemicals, glutathione depletion, and other forms of stressP Pappas, V Vasiliou, D W Nebert, et al.Biochimica Et Biophysica Acta|July 21, 1977
Comparative EPR study on high-spin ferric porphine complexes and cytochrome P-450 having rhombic characterM Sato, H Kon, K Kumaki, et al.Molecular Endocrinology (Baltimore, Md.)|April 1, 1987
Comparison of human mouse P1450 upstream regulatory sequences in liver- and nonliver-derived cell linesA K Jaiswal, F J Gonzalez, D W NebertDevelopmental Pharmacology and Therapeutics|January 1, 1980
Genetic differences in phenytoin pharmacokinetics. In vivo clearance and in vitro metabolism among inbred strains of miceS A Atlas, J L Zweier, D W NebertAnalytical Biochemistry|April 1, 1983
Sulfobetaine derivatives of bile acids: nondenaturing surfactants for membrane biochemistryL M Hjelmeland, D W Nebert, J C OsbornePageof 31